The Protein Level of PGC-1α, a Key Metabolic Regulator, Is Controlled by NADH-NQO1

REFERENCES

• Baar K, Wende AR, Jones TE, Marison M, Nolte LA, Chen M, Kelly DP, Holloszy JO. 2002. Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB J. 16:1879–1886.
   PubMed Web of Science ®Google Scholar
• Michael LF, Wu Z, Cheatham RB, Puigserver P, Adelmant G, Lehman JJ, Kelly DP, Spiegelman BM. 2001. Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1. Proc. Natl. Acad. Sci. U. S. A. 98:3820–3825.
   PubMed Web of Science ®Google Scholar
• Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, Spiegelman BM. 1999. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98:115–124.
   PubMed Web of Science ®Google Scholar
• Herzig S, Long F, Jhala US, Hedrick S, Quinn R, Bauer A, Rudolph D, Schutz G, Yoon C, Puigserver P, Spiegelman B, Montminy M. 2001. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413:179–183.
   PubMed Web of Science ®Google Scholar
• Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, Newgard CB, Spiegelman BM. 2001. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413:131–138.
   PubMed Web of Science ®Google Scholar
• Estall JL, Kahn M, Cooper MP, Fisher FM, Wu MK, Laznik D, Qu L, Cohen DE, Shulman GI, Spiegelman BM. 2009. Sensitivity of lipid metabolism and insulin signaling to genetic alterations in hepatic peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression. Diabetes 58:1499–1508.
   PubMed Web of Science ®Google Scholar
• Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. 1998. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92:829–839.
   PubMed Web of Science ®Google Scholar
• St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jager S, Handschin C, Zheng K, Lin J, Yang W, Simon DK, Bachoo R, Spiegelman BM. 2006. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127:397–408.
   PubMed Web of Science ®Google Scholar
• Valle I, Alvarez-Barrientos A, Arza E, Lamas S, Monsalve M. 2005. PGC-1alpha regulates the mitochondrial antioxidant defense system in vascular endothelial cells. Cardiovasc. Res. 66:562–573.
   PubMed Web of Science ®Google Scholar
• Sahin E, Colla S, Liesa M, Moslehi J, Muller FL, Guo M, Cooper M, Kotton D, Fabian AJ, Walkey C, Maser RS, Tonon G, Foerster F, Xiong R, Wang YA, Shukla SA, Jaskelioff M, Martin ES, Heffernan TP, Protopopov A, Ivanova E, Mahoney JE, Kost-Alimova M, Perry SR, Bronson R, Liao R, Mulligan R, Shirihai OS, Chin L, DePinho RA. 2011. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 470:359–365.
   PubMed Web of Science ®Google Scholar
• Finck BN, Kelly DP. 2006. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J. Clin. Invest. 116:615–622.
   PubMed Web of Science ®Google Scholar
• Wenz T. 2009. PGC-1alpha activation as a therapeutic approach in mitochondrial disease. IUBMB Life 61:1051–1062.
   PubMedGoogle Scholar
• Rona-Voros K, Weydt P. 2010. The role of PGC-1alpha in the pathogenesis of neurodegenerative disorders. Curr. Drug Targets 11:1262–1269.
   PubMedGoogle Scholar
• Canto C, Auwerx J. 2009. PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr. Opin. Lipidol. 20:98–105.
   PubMed Web of Science ®Google Scholar
• Schilling J, Kelly DP. 2011. The PGC-1 cascade as a therapeutic target for heart failure. J. Mol. Cell. Cardiol. 51:578–583.
   PubMedGoogle Scholar
• Qatanani M, Lazar MA. 2007. Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev. 21:1443–1455.
   PubMed Web of Science ®Google Scholar
• Cao W, Daniel KW, Robidoux J, Puigserver P, Medvedev AV, Bai X, Floering LM, Spiegelman BM, Collins S. 2004. p38 mitogen-activated protein kinase is the central regulator of cyclic AMP-dependent transcription of the brown fat uncoupling protein 1 gene. Mol. Cell. Biol. 24:3057–3067.
   PubMed Web of Science ®Google Scholar
• Handschin C, Rhee J, Lin J, Tarr PT, Spiegelman BM. 2003. An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle. Proc. Natl. Acad. Sci. U. S. A. 100:7111–7116.
   PubMed Web of Science ®Google Scholar
• Jager S, Handschin C, St-Pierre J, Spiegelman BM. 2007. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc. Natl. Acad. Sci. U. S. A. 104:12017–12022.
   PubMed Web of Science ®Google Scholar
• Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. 2005. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434:113–118.
   PubMed Web of Science ®Google Scholar
• Canto C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, Elliott PJ, Puigserver P, Auwerx J. 2009. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458:1056–1060.
   PubMed Web of Science ®Google Scholar
• Olson BL, Hock MB, Ekholm-Reed S, Wohlschlegel JA, Dev KK, Kralli A, Reed SI. 2008. SCFCdc4 acts antagonistically to the PGC-1alpha transcriptional coactivator by targeting it for ubiquitin-mediated proteolysis. Genes Dev. 22:252–264.
   PubMed Web of Science ®Google Scholar
• Anderson RM, Barger JL, Edwards MG, Braun KH, O'Connor CE, Prolla TA, Weindruch R. 2008. Dynamic regulation of PGC-1alpha localization and turnover implicates mitochondrial adaptation in calorie restriction and the stress response. Aging Cell 7:101–111.
   PubMed Web of Science ®Google Scholar
• Trausch-Azar J, Leone TC, Kelly DP, Schwartz AL. 2010. Ubiquitin proteasome dependent degradation of the transcriptional coactivator PGC-1alpha via the N-terminal pathway. J. Biol. Chem. 285:40192–40200.
   PubMed Web of Science ®Google Scholar
• Sano M, Tokudome S, Shimizu N, Yoshikawa N, Ogawa C, Shirakawa K, Endo J, Katayama T, Yuasa S, Ieda M, Makino S, Hattori F, Tanaka H, Fukuda K. 2007. Intramolecular control of protein stability, subnuclear compartmentalization, and coactivator function of peroxisome proliferator-activated receptor gamma coactivator 1alpha. J. Biol. Chem. 282:25970–25980.
   PubMed Web of Science ®Google Scholar
• Wei P, Pan D, Mao C, Wang YX. 2012. RNF34 is a cold-regulated E3 ubiquitin ligase for PGC-1alpha and modulates brown fat cell metabolism. Mol. Cell. Biol. 32:266–275.
   PubMed Web of Science ®Google Scholar
• Asher G, Reuven N, Shaul Y. 2006. 20S proteasomes and protein degradation “by default.” Bioessays 28:844–849.
   PubMed Web of Science ®Google Scholar
• Shaul Y, Tsvetkov P, Reuven N. 2010. IDPs and protein degradation in the cell, p 3–36. In Uversky VN, Longhi S (ed), Instrumental analysis of intrinsically disordered proteins: assessing structure and conformation. John Wiley & Sons, Inc, Hoboken, NJ.
   Google Scholar
• Tompa P. 2005. The interplay between structure and function in intrinsically unstructured proteins. FEBS Lett. 579:3346–3354.
   PubMed Web of Science ®Google Scholar
• Uversky VN, Dunker AK. 2010. Understanding protein non-folding. Biochim. Biophys. Acta 1804:1231–1264.
   PubMed Web of Science ®Google Scholar
• Babu MM, van der Lee R, de Groot NS, Gsponer J. 2011. Intrinsically disordered proteins: regulation and disease. Curr. Opin. Struct. Biol. 21:432–440.
   PubMed Web of Science ®Google Scholar
• Scarpulla RC. 2011. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim. Biophys. Acta 1813:1269–1278.
   PubMed Web of Science ®Google Scholar
• Liu C, Lin JD. 2011. PGC-1 coactivators in the control of energy metabolism. Acta Biochim. Biophys. Sin. (Shanghai) 43:248–257.
   PubMed Web of Science ®Google Scholar
• Sugden MC, Caton PW, Holness MJ. 2010. PPAR control: it's SIRTainly as easy as PGC. J. Endocrinol. 204:93–104.
   PubMed Web of Science ®Google Scholar
• Hwang JH, Kim DW, Jo EJ, Kim YK, Jo YS, Park JH, Yoo SK, Park MK, Kwak TH, Kho YL, Han J, Choi HS, Lee SH, Kim JM, Lee I, Kyung T, Jang C, Chung J, Kweon GR, Shong M. 2009. Pharmacological stimulation of NADH oxidation ameliorates obesity and related phenotypes in mice. Diabetes 58:965–974.
   PubMed Web of Science ®Google Scholar
• Gaikwad A, Long DJII, Stringer JL, Jaiswal AK. 2001. In vivo role of NAD(P)H:quinone oxidoreductase 1 (NQO1) in the regulation of intracellular redox state and accumulation of abdominal adipose tissue. J. Biol. Chem. 276:22559–22564.
   PubMed Web of Science ®Google Scholar
• Lee JS, Park AH, Lee SH, Kim JH, Yang SJ, Yeom YI, Kwak TH, Lee D, Lee SJ, Lee CH, Kim JM, Kim D. 2012. Beta-lapachone, a modulator of NAD metabolism, prevents health declines in aged mice. PLoS One 7:e47122. doi:10.1371/journal.pone.0047122.
   PubMedGoogle Scholar
• Ross D. 2004. Quinone reductases multitasking in the metabolic world. Drug Metab. Rev. 36:639–654.
   PubMed Web of Science ®Google Scholar
• Asher G, Tsvetkov P, Kahana C, Shaul Y. 2005. A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73. Genes Dev. 19:316–321.
   PubMed Web of Science ®Google Scholar
• Moscovitz O, Tsvetkov P, Hazan N, Michaelevski I, Keisar H, Ben-Nissan G, Shaul Y, Sharon M. 2012. A mutually inhibitory feedback loop between the 20S proteasome and its regulator, NQO1. Mol. Cell 47:76–86.
   PubMedGoogle Scholar
• Hershkovitz Rokah O, Shpilberg O, Granot G. 2010. NAD(P)H quinone oxidoreductase protects TAp63gamma from proteasomal degradation and regulates TAp63gamma-dependent growth arrest. PLoS One 5:e11401. doi:10.1371/journal.pone.0011401.
   PubMedGoogle Scholar
• Garate M, Wong RP, Campos EI, Wang Y, Li G. 2008. NAD(P)H quinone oxidoreductase 1 inhibits the proteasomal degradation of the tumour suppressor p33(ING1b). EMBO Rep. 9:576–581.
   PubMedGoogle Scholar
• Asher G, Bercovich Z, Tsvetkov P, Shaul Y, Kahana C. 2005. 20S proteasomal degradation of ornithine decarboxylase is regulated by NQO1. Mol. Cell 17:645–655.
   PubMed Web of Science ®Google Scholar
• Patrick BA, Gong X, Jaiswal AK. 2011. Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to 20S proteasomal degradation of p63 resulting in thinning of epithelium and chemical-induced skin cancer. Oncogene 30:1098–1107.
   PubMedGoogle Scholar
• Adler J, Reuven N, Kahana C, Shaul Y. 2010. c-Fos proteasomal degradation is activated by a default mechanism, and its regulation by NAD(P)H:quinone oxidoreductase 1 determines c-Fos serum response kinetics. Mol. Cell. Biol. 30:3767–3778.
   PubMedGoogle Scholar
• Patrick BA, Jaiswal AK. 2012. Stress-induced NQO1 controls stability of C/EBPalpha against 20S proteasomal degradation to regulate p63 expression with implications in protection against chemical-induced skin cancer. Oncogene 31:4362–4371.
   PubMed Web of Science ®Google Scholar
• Sollner S, Schober M, Wagner A, Prem A, Lorkova L, Palfey BA, Groll M, Macheroux P. 2009. Quinone reductase acts as a redox switch of the 20S yeast proteasome. EMBO Rep. 10:65–70.
   PubMedGoogle Scholar
• Levy D, Adamovich Y, Reuven N, Shaul Y. 2007. The Yes-associated protein 1 stabilizes p73 by preventing Itch-mediated ubiquitination of p73. Cell Death Differ. 14:743–751.
   PubMedGoogle Scholar
• Lin J, Wu PH, Tarr PT, Lindenberg KS, St-Pierre J, Zhang CY, Mootha VK, Jager S, Vianna CR, Reznick RM, Cui L, Manieri M, Donovan MX, Wu Z, Cooper MP, Fan MC, Rohas LM, Zavacki AM, Cinti S, Shulman GI, Lowell BB, Krainc D, Spiegelman BM. 2004. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 119:121–135.
   PubMed Web of Science ®Google Scholar
• Zammit PS, Relaix F, Nagata Y, Ruiz AP, Collins CA, Partridge TA, Beauchamp JR. 2006. Pax7 and myogenic progression in skeletal muscle satellite cells. J. Cell Sci. 119:1824–1832.
   PubMed Web of Science ®Google Scholar
• Luo J, Deng ZL, Luo X, Tang N, Song WX, Chen J, Sharff KA, Luu HH, Haydon RC, Kinzler KW, Vogelstein B, He TC. 2007. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat. Protoc. 2:1236–1247.
   PubMed Web of Science ®Google Scholar
• Fulco M, Cen Y, Zhao P, Hoffman EP, McBurney MW, Sauve AA, Sartorelli V. 2008. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev. Cell 14:661–673.
   PubMed Web of Science ®Google Scholar
• Krishna TS, Kong XP, Gary S, Burgers PM, Kuriyan J. 1994. Crystal structure of the eukaryotic DNA polymerase processivity factor PCNA. Cell 79:1233–1243.
   PubMed Web of Science ®Google Scholar
• Tompa P. 2002. Intrinsically unstructured proteins. Trends Biochem. Sci. 27:527–533.
   PubMed Web of Science ®Google Scholar
• Devarakonda S, Gupta K, Chalmers MJ, Hunt JF, Griffin PR, Van Duyne GD, Spiegelman BM. 2011. Disorder-to-order transition underlies the structural basis for the assembly of a transcriptionally active PGC-1alpha/ERRgamma complex. Proc. Natl. Acad. Sci. U. S. A. 108:18678–18683.
   PubMedGoogle Scholar
• Liu CW, Corboy MJ, DeMartino GN, Thomas PJ. 2003. Endoproteolytic activity of the proteasome. Science 299:408–411.
   PubMed Web of Science ®Google Scholar
• Tsvetkov P, Asher G, Paz A, Reuven N, Sussman JL, Silman I, Shaul Y. 2008. Operational definition of intrinsically unstructured protein sequences based on susceptibility to the 20S proteasome. Proteins 70:1357–1366.
   PubMedGoogle Scholar
• Tsvetkov P, Shaul Y. 2012. Determination of IUP based on susceptibility for degradation by default. Methods Mol. Biol. 895:3–18.
   PubMedGoogle Scholar
• Tsvetkov P, Reuven N, Shaul Y. 2009. The nanny model for IDPs. Nat. Chem. Biol. 5:778–781.
   PubMed Web of Science ®Google Scholar
• Uversky VN, Oldfield CJ, Dunker AK. 2008. Intrinsically disordered proteins in human diseases: introducing the D2 concept. Annu. Rev. Biophys. 37:215–246.
   PubMed Web of Science ®Google Scholar
• Asher G, Dym O, Tsvetkov P, Adler J, Shaul Y. 2006. The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol. Biochemistry 45:6372–6378.
   PubMed Web of Science ®Google Scholar
• Ma Q, Cui K, Xiao F, Lu AY, Yang CS. 1992. Identification of a glycine-rich sequence as an NAD(P)H-binding site and tyrosine 128 as a dicumarol-binding site in rat liver NAD(P)H:quinone oxidoreductase by site-directed mutagenesis. J. Biol. Chem. 267:22298–22304.
   PubMedGoogle Scholar
• Fulco M, Schiltz RL, Iezzi S, King MT, Zhao P, Kashiwaya Y, Hoffman E, Veech RL, Sartorelli V. 2003. Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Mol. Cell 12:51–62.
   PubMed Web of Science ®Google Scholar
• Dinkova-Kostova AT, Talalay P. 2010. NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector. Arch. Biochem. Biophys. 501:116–123.
   PubMed Web of Science ®Google Scholar
• Bitterman KJ, Anderson RM, Cohen HY, Latorre-Esteves M, Sinclair DA. 2002. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J. Biol. Chem. 277:45099–45107.
   PubMed Web of Science ®Google Scholar
• Daitoku H, Yamagata K, Matsuzaki H, Hatta M, Fukamizu A. 2003. Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR. Diabetes 52:642–649.
   PubMed Web of Science ®Google Scholar
• Louet JF, Hayhurst G, Gonzalez FJ, Girard J, Decaux JF. 2002. The coactivator PGC-1 is involved in the regulation of the liver carnitine palmitoyltransferase I gene expression by cAMP in combination with HNF4 alpha and cAMP-response element-binding protein (CREB). J. Biol. Chem. 277:37991–38000.
   PubMed Web of Science ®Google Scholar
• Cooper MP, Qu L, Rohas LM, Lin J, Yang W, Erdjument-Bromage H, Tempst P, Spiegelman BM. 2006. Defects in energy homeostasis in Leigh syndrome French Canadian variant through PGC-1alpha/LRP130 complex. Genes Dev. 20:2996–3009.
   PubMedGoogle Scholar
• Williamson DH, Lund P, Krebs HA. 1967. The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem. J. 103:514–527.
   PubMed Web of Science ®Google Scholar
• Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, Oriente F, Kitamura Y, Altomonte J, Dong H, Accili D, Spiegelman BM. 2003. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 423:550–555.
   PubMed Web of Science ®Google Scholar
• Li X, Monks B, Ge Q, Birnbaum MJ. 2007. Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1alpha transcription coactivator. Nature 447:1012–1016.
   PubMed Web of Science ®Google Scholar
• Ross D, Siegel D. 2004. NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics. Methods Enzymol. 382:115–144.
   PubMed Web of Science ®Google Scholar
• Gsponer J, Futschik ME, Teichmann SA, Babu MM. 2008. Tight regulation of unstructured proteins: from transcript synthesis to protein degradation. Science 322:1365–1368.
   PubMed Web of Science ®Google Scholar
• Rosenfeld N, Alon U. 2003. Response delays and the structure of transcription networks. J. Mol. Biol. 329:645–654.
   PubMedGoogle Scholar
• Belle A, Tanay A, Bitincka L, Shamir R, O'Shea EK. 2006. Quantification of protein half-lives in the budding yeast proteome. Proc. Natl. Acad. Sci. U. S. A. 103:13004–13009.
   PubMed Web of Science ®Google Scholar
• Tsvetkov P, Reuven N, Prives C, Shaul Y. 2009. The susceptibility of the p53 unstructured N-terminus to 20S proteasomal degradation programs stress response. J. Biol. Chem. 284:26234–26242.
   PubMedGoogle Scholar
• Kim SY, Jeoung NH, Oh CJ, Choi YK, Lee HJ, Kim HJ, Kim JY, Hwang JH, Tadi S, Yim YH, Lee KU, Park KG, Huh S, Min KN, Jeong KH, Park MG, Kwak TH, Kweon GR, Inukai K, Shong M, Lee IK. 2009. Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation. Circ. Res. 104:842–850.
   PubMedGoogle Scholar